by Bareli, T., Ahdoot, H. L., Ben Moshe, H., Barnea, R., Warhaftig, G., Gispan, I., Maayan, R., Rosca, P., Weizman, A., and Yadid, G. (2021). Front. Behav. Neurosci. 15:788708. doi: 10.3389/fnbeh.2021.788708
Due to a production error, an author name was incorrectly spelled as Hilla Ben Moshe. The correct spelling is Hila Ben Moshe.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: stress, substance-induced depressive disorder, addiction, treatment, therapeutic center, baclofen, opipramol
Citation: Frontiers Production Office (2022) Erratum: Novel Opipramol-Baclofen Combination Alleviates Depression and Craving and Facilitates Recovery From Substance Use Disorder—An Animal Model and a Human Study. Front. Behav. Neurosci. 16:952004. doi: 10.3389/fnbeh.2022.952004
Received: 24 May 2022; Accepted: 24 May 2022;
Published: 10 June 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn